Cargando…
A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065630/ https://www.ncbi.nlm.nih.gov/pubmed/21461307 http://dx.doi.org/10.5045/kjh.2011.46.1.57 |
_version_ | 1782201006086422528 |
---|---|
author | Kim, Seok Jin |
author_facet | Kim, Seok Jin |
author_sort | Kim, Seok Jin |
collection | PubMed |
description | |
format | Text |
id | pubmed-3065630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-30656302011-03-31 A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma Kim, Seok Jin Korean J Hematol Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011-03 2011-03-15 /pmc/articles/PMC3065630/ /pubmed/21461307 http://dx.doi.org/10.5045/kjh.2011.46.1.57 Text en © 2011 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Kim, Seok Jin A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma |
title | A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma |
title_full | A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma |
title_fullStr | A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma |
title_full_unstemmed | A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma |
title_short | A therapeutic dilemma between the two "R"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large B-cell lymphoma |
title_sort | therapeutic dilemma between the two "r"s: additional rituximab or radiotherapy for limited, non-bulky diffuse large b-cell lymphoma |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065630/ https://www.ncbi.nlm.nih.gov/pubmed/21461307 http://dx.doi.org/10.5045/kjh.2011.46.1.57 |
work_keys_str_mv | AT kimseokjin atherapeuticdilemmabetweenthetworsadditionalrituximaborradiotherapyforlimitednonbulkydiffuselargebcelllymphoma AT kimseokjin therapeuticdilemmabetweenthetworsadditionalrituximaborradiotherapyforlimitednonbulkydiffuselargebcelllymphoma |